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Abstract: The aim of the study was to explore the differences between Brazilian and Portuguese
patients with fibromyalgia (FM) syndrome in their experience of fatigue, and to measure differences
in the perception of fatigue as a function of age and duration of the diagnosis. In total, 209 Portuguese
women aged between 21 and 75 years (M = 47.44; SD = 10.73) and 429 Brazilian women aged
between 18 and 77 years (M = 46.51; SD = 9.24) were recruited to participate in the present study.
Participants completed the Multidimensional Daily Diary of Fatigue-Fibromyalgia-17 items (MDF-
Fibro-17), a specific tool to measure the level of five components of FM-related fatigue. Results
showed greater perception of all the components of fatigue in the Brazilian sample. No significant
differences were found related to age and duration of FM diagnosis. The multifaceted nature of FM
and cultural differences suggests that individualized treatment programs may be necessary to reduce
fatigue-related symptoms in patients with this syndrome.
Keywords: fibromyalgia; fatigue; MDF-Fibro-17; cross-cultural comparison
1. Introduction
Fibromyalgia (FM) syndrome is one of the most common symptoms of chronic mus-
culoskeletal pain and affects mostly the mid-adult population (between 30 and 50 years
old), predominately women [1,2]. It is estimated that between 2% and 4% of the world
population suffers from FM [3].
Although there is no certainty about the origin of FM, it is currently known that there
is a relationship between the nervous system and neurochemical imbalance for the appear-
ance of the first symptoms of this syndrome [4]. The main symptoms reported by patients
include musculoskeletal pain without external stimuli, specific places of musculoskeletal
sensitivity (also called tender points), decreased muscle strength, chronic fatigue syndrome,
and psychological adversities such as sleep disorders, anxiety, and depression [5,6]. FM is
considered a multifactorial health condition, that is, its symptoms worsen or are maintained
based on the interaction of several biological, psychological, and social factors [7].
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Considering the multiple factors that FM involves, the pharmacological treatment for
this disease turns out to be generic, only based on the signs and symptoms presented by
the patient during the crises [4]. For a doctor to diagnose FM, the patient must achieve high
scores in two validated questionnaires by the American College of Rheumatology [8,9].
One of the questionnaires measures pain severity and the other generalized muscle pain
intensity [9]. After combining the results of these two questionnaires, and without any
change in symptom intensity for more than three months, then the diagnosis of FM is
feasible [10]. Fatigue seems to be one of the main symptoms of FM, which patients report
to be one of the most disabling harms, thus interfering drastically in their wellbeing and
overall quality of life [8,11–13]. Recent evidence found that FM patients show less quality
of life when compared to people with any other rheumatic disease or syndrome [14,15].
As it stands, fatigue seems to be one of the main disabling symptoms, hindering daily
task performance as well as engagement in structured physical exercise [16]. The inability
to perform work or day-to-day tasks, not fully understanding the symptoms, feeling
of disability, negative impact on interpersonal relationships, isolation, social exclusion,
and the difficulty in controlling various symptoms end up leading to a deterioration in the
quality of life [17,18]. This causes a significant worsening of health status, both physical and
mental, which ends up increasing the severity of the syndrome and its related symptoms
in patients with FM [17,18].
1.1. Differences between Portugal and Brazil in Fatigue-Related Symptoms
Although similar in language (i.e., Portuguese), Portugal and Brazil seem to display
some differences regarding FM and fatigue-related symptoms. In Portugal, the prevalence
of the disease is 2.1% of the population, that is, more than 200,000 people have been
diagnosed with FM, with the proportion that there are six women with FM for each man
with a positive diagnosis [19,20]. A study conducted by Branco et al. [8] showed that
Portugal has more patients with FM when compared to other countries in Western Europe,
such as Spain, France, Germany, and Italy, which may demonstrate a greater need to
explore and examine possible factors and symptoms related to FM. In the economic scope
of this syndrome, it is estimated that diseases that have chronic pain-related symptoms
(e.g., FM) can cause an average of six annual consultations, generating direct and indirect
costs to public health [21].
In Brazil, it is estimated that 2.5% of the population has FM, which represents approxi-
mately 4.2 million Brazilians with FM, and the ratio between men and women diagnosed
with FM is 1:5.5 [22]. However, in Brazil, due to social disparity and geographical distances
from health care centers, patients with FM have more difficulties accessing the necessary
care and treatment [21].
In other cross-cultural comparison studies, Kuppens et al. [23] demonstrated that there
were significant differences when comparing the perception of fatigue-related symptoms
between Belgian and Dutch patients with FM, where Belgian patients reported greater
intensity severity in fatigue levels compared to Dutch patients. In this same study, Belgian
patients attributed this difference in perception to external factors (i.e., workload, envi-
ronmental and weather conditions, physical and/or psychological trauma), while Dutch
patients attributed fatigue and other FM symptoms to internal factors (i.e., genetic disorders,
personality, etc.).
Differences in perceptions of fatigue and FM symptoms were also reported by Ruiz-
Montero et al. [24], where it was found that Spanish patients had higher values of perception
of FM symptoms compared to patients from Sweden, Belgium, and Holland. Clark et al. [25]
compared the perception of FM symptoms between patients in Europe and Latin America,
and found that Latin American patients had a greater perception of fatigue and other FM
symptoms than European patients. These differences suggest that the perception of fatigue
may vary across cultures, even in bordering countries with somewhat similar cultural
characteristics (e.g., Belgium and Holland).
Medicina 2021, 57, 322 3 of 9
1.2. Associations between Age, Time of Diagnosis, and Fatigue-Related Symptoms
In the current literature, there is still limited evidence on the effects of fatigue and its
relationship with patient’s age and time of diagnosis. Studies have shown that FM-related
symptoms are more pronounced in younger patients compared to older patients [26–29].
These differences in the perception of fatigue between younger and older patients can be
explained by lack of experience in controlling this syndrome, which may cause higher
levels of symptom intensity when these are reported by younger patients in comparison to
older ones [27,30]. Kennedy and Felson [31] carried out a longitudinal study where they
monitored the perception of FM symptoms among patients from the day they received
the diagnosis and after 10 years. The results showed that in that 10-year period there was
a decrease in the scores of fatigue and the general symptoms of FM compared to date of
diagnosis. Walitt et al. [32] in their study also used the same research criterion, and 11 years
after the first diagnosis, those patients also reported a decrease in the general perception of
FM. However, there is a lack of studies regarding the relationship between fatigue-related
symptoms, time of diagnosis, and age in FM patients. These studies shed some light on the
differences among time of diagnosis and years after dealing with FM.
1.3. Current Research
This study aimed to address existing limitations and provide an important incre-
mental step forward regarding how Portuguese and Brazilian women patients with FM
experience fatigue-related symptoms, and if there could be cultural differences between
them. Thus, the aim of the study was to explore the differences between fatigue-related
symptoms in Brazilian and Portuguese women with FM syndrome. The second aim was
to examine associations between age, time of diagnosis, and fatigue-related symptoms in
both countries.
2. Materials and Methods
2.1. Participants
Data from two independent samples were collected for the present study. The first
sample (Sample 1) comprised data from 290 Portuguese women aged between 21 and
75 years (M = 47.44 ± 10.73) who were invited to participate in the present study. Mean
time diagnosis for FM ranged between 1 and 30 years (M = 7.71 ± 6.04), referred by
rheumatologists following the suggested patterns for diagnosis of this syndrome. The sec-
ond sample (Sample 2) comprised data from 429 Brazilian women aged between 18 and
77 years old (M = 46.52; SD = 9.23). Mean time diagnosis for FM ranged between 1 and
30 years (M = 7.86 ± 6.48). The participants of this research were diagnosed with FM
by licensed rheumatologists and their diagnosis was established by the recommended
guidelines proposed by the American College of Rheumatology [9].
2.2. Data Collection Procedures
Before data collection, ethical approval was obtained from the ethical and scientific
committee of the Center for Research in Sport, Health and Human Development (CIDESD)
under the registration number UID04045/2020. Researchers contacted several hospital
boards and health care centers (n = 10) to obtain permission to conduct the present research.
At this stage, the objectives of the study were explained and endorsement from each board
was obtained. Next, rheumatologists (n = 8) administered the questionnaire to patients
with FM, according to the previously mentioned inclusion criteria. All individuals partici-
pated voluntarily in this study, receiving no monetary reward for their contribution and
were informed about the study objectives and gave informed consent before participat-
ing. The current study was conducted in accordance with the Helsinki declaration and
later amendments.
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2.3. Instrument
The Multidimensional Daily Diary of Fatigue-Fibromyalgia-17 items (MDF-fibro-17)
validated for Brazilian and Portuguese populations was used to measure fatigue-related
symptoms of FM [33]. The 17 items consist of five subscales: global fatigue experience
(four items; item example, “How severe was your fatigue today?”); physical fatigue (three
items; item example, “How weak were your muscles today?”); cognitive fatigue (four items;
item example, “How hard was it to concentrate because you were tired today?”); motivation
(three items; item example, “How much effort was made today?”); and impact on function
(three items; item example, “Did you do things more slowly because you were tired today?”).
Participants responded to each item using a 10-point scale, ranging from 0 (“nothing”) to
10 (“extremely”). Higher scores indicated greater fatigue severity. Previous studies support
the validity and reliability of this questionnaire [7].
2.4. Statistical Analysis
Data were initially exported to IBM SPSS STATISTICS v.23 (IBM Corp., Armonk, NY, USA)
for preliminary analyses. Descriptive statistics, including mean, standard deviation, skewness,
and kurtosis were calculated for all studied variables in both samples. Cutoffs for normality
were determined based on traditional guidelines, accepting scores within −2/+2 and −7/+7
for skewness and kurtosis, respectively. Inspection of missing values and outliers was also
carried out.
Subsequently, a t-test for the independent sample was used to analyze differences
between fatigue-related symptoms in Brazilian and Portuguese female patients with FM,
as well as between time of diagnosis. The Cohen’s d was calculated to obtain the corre-
spondent effect size for t-test analysis, considered as: trivial (0.00–0.19); small (0.20–0.49),
average (0.50–0.79), and large (greater than or equal to 0.80).
In the following step, Pearson bivariate correlations were calculated between age, time
of diagnosis, and fatigue-related symptoms in each sample. A p-value of less than 0.05 was
considered significant.
3. Results
3.1. Preliminary Analysis and Comparison of Fatigue Components between Brazil and Portugal
Inspection of the data showed no missing values and outliers. The descriptive statistics
of all fatigue-related symptoms are summarized in Table 1. Examining mean values,
Brazilian women reported higher scores in all fatigue-related symptoms compared to
Portuguese women. Results revealed no violations of the univariate distribution since
skewness and kurtosis were contained between −2 and +2, and −7 and +7, respectively.
Table 1. Descriptive statistics of each variable according to samples (Portugal and Brazil).
N M SD S K t df p-Value d
Global
experience
Portugal 290 7.25 1.58 −0.75 0.49 −3.690 717 <0.001 0.28Brazil 429 7.72 1.74 −0.97 0.70
Physical
fatigue
Portugal 290 7.50 1.64 −0.95 1.18 −5.898 717 <0.001 0.44Brazil 429 8.22 1.59 −1.02 0.67
Cognitive
fatigue
Portugal 290 7.20 1.86 −0.90 0.89 −4.848 717 <0.001 0.37Brazil 429 7.88 1.82 −1.32 1.99
Motivation
Portugal 290 7.50 1.70 −0.89 0.73 −5.312 717 <0.001 0.40Brazil 429 8.19 1.71 −1.18 1.10
Impact on
function
Portugal 290 7.45 1.83 −1.15 1.20 −5.847 717 <0.001 0.45Brazil 429 8.27 1.80 −1.67 2.45
Note. N = sample size; M = mean; SD = standard deviation; S = skewness; k = kurtosis; d = effect size.
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The analysis of the t-test for independent samples showed that there were significant
differences in all fatigue-related symptoms as a function of country (p < 0.01). Effect sizes
were small, ranging between 0.28 and 0.45. For detailed information see Table 1.
3.2. Associations between Age, Time of Diagnosis, and Fatigue-Related Symptoms
Correlations between age, time of diagnosis, and fatigue-related symptoms in both
countries are reported in Table 2. Global experience, physical fatigue, cognitive fatigue,
motivation, and impact on function were not significantly correlated with age. Similarly,
fatigue-related symptoms were not significantly correlated with time of diagnosis in the
Brazilian and Portuguese female patients with FM. Details are displayed in Table 2.
Table 2. Correlation between age, time of diagnosis, and fatigue in Portugal and Brazil.
Variables
Portugal Brazil
Age Time of Diagnosis Age Time of Diagnosis
Global
experience 0.03 0.00 −0.04 0.01
Physical fatigue 0.06 0.02 −0.01 0.03
Cognitive
fatigue 0.04 −0.01 −0.04 0.02
Motivation 0.06 0.01 −0.04 −0.01
Impact on
function 0.06 0.05 −0.04 0.01
4. Discussion
The present research focused on the study of fatigue as one of the main symptoms in
Brazilian and Portuguese women with FM. The MDF-Fibro-17 validated for the Brazilian
and Portuguese population was used to measure the level of five components of FM-related
fatigue symptoms in a large sample of female patients from Brazil (n = 429) and Portugal
(n = 290). The aim of the study was to explore the differences between Brazilian and
Portuguese patients in their experience of fatigue. Additionally, associations between
fatigue, age, and duration of the diagnosis were carried out in both samples under analysis.
Results showed greater perception of all the components of fatigue in the Brazilian sample.
No other significant differences were found related to the age of the patients and the
duration of FM diagnosis. Implications derived from this study in relationship to fatigue
in FM will be discussed according to existing literature.
4.1. Comparison of Fatigue Components between Brazil and Portugal
The present results suggest that Brazilian women with FM, when compared to
Portuguese women, tend to have more pronounced perception of fatigue-related symp-
toms compared to Portuguese patients. This finding is consistent with previous studies
(e.g., Clark et al. [25]), where European FM patients displayed significant differences
in fatigue-related symptoms. The study by Ruiz-Montero et al. [34] found that Spanish
women had higher perceptions of FM-related syndrome and higher levels of fatigue-related
symptoms than Dutch women. This same panorama was verified in studies by Liedberg,
Burckhardt, and Henriksson [35], where different cultures have different perceptions of FM
and levels of fatigue from each other. Kuppens et al. [23] in their study made a comparison
of the perception of FM symptoms in Belgians and Dutch, and found that Belgian patients
had higher perceptions of the symptoms; that is, they more felt the effects caused by fatigue
and the other symptoms of FM. Liedberg, Burckhardt, and Henriksson [35], on the other
hand, carried out a comparative study between patients from Sweden and the United
States with FM, where they demonstrated that North American patients felt the effects of
fatigue and other symptoms of FM more than Swedish ones. Thus, it seems that European
countries, compared to American countries, tend to perceive fatigue-related symptoms less.
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These cultural differences in the perception of FM fatigue may suggest that these
different levels of perception may be due to external reasons or even to local influences
(that is, differences in the health system, sociodemographic factors, stress levels, weather
conditions). These external reasons seem to be related to the differences in symptoms
related to fatigue between Brazilian and Portuguese women with FM. Brazil has a larger
geographic proportion, making access to health care more difficult. In addition, Brazil ends
up having different social realities between states and regions compared to Portugal, which
ends up generating social inequalities, thus delaying the diagnosis of FM syndrome and its
pharmacological and non-pharmacological treatments [22].
4.2. Associations between Age and Fatigue-Related Symptoms of Brazilian and Portuguese
Patients with FM
The present study showed that fatigue components were not significantly associated
with age, regardless of country as demonstrated by the values presented in Table 2 (p > 0.05).
This suggests that fatigue does not vary significantly over time regarding FM patients’
perceptions. This is in line with Salinem et al. [35], who demonstrated that fatigue is a
longitudinal experience that is maintained throughout the life of patients with FM, without
significant changes.
However, the results of this study differ from some studies in the literature, which found
that there are differences in the perception of fatigue among younger patients compared to
older patients [26,28,29]. The study by Shillam, Jones, and Miller [26] made a comparison
between the perception of FM symptoms between middle-aged adult patients and older
patients, and the younger ones were found to be more symptomatic, that is, they had greater
symptom intensity when compared to older patients. Keskindag [28] in his study compared
the perception of fatigue between three age groups (i.e., group 1 = 30–39-year-old patients;
group 2 = 40–49-year-old patients; and group 3 = 50–59-year-old patients), and the authors
concluded that younger patients (group 1) had higher levels of fatigue when compared
to adults in the other groups. Similar findings to this were found by Jiao et al. [29] when
comparing fatigue-related symptoms between different age groups. These authors found
that after aggregating patients into age groups: group 1 = 18–39 years; group 2 = 40–59 years;
and group 3 = > 60 years, younger patients (group 1) had higher levels of fatigue and other
symptoms compared to FM patients in groups 2 and 3.
4.3. Associations between Time of Diagnosis and Fatigue-Related Symptoms of Brazilian and
Portuguese Patients with FM
When analyzing the relationship between fatigue domains and time of diagnosis,
results showed that there were no significant differences in both Brazilian and Portuguese
samples of women with FM. The results show that the time of diagnosis is not related to
the symptoms of fatigue. This result differs from the studies by Kennedy and Felson [31],
Walitt et al. [32], and White et al. [36], who followed women newly diagnosed with FM for 3,
10, and 11 years to determine whether the time of diagnosis had an effect on the perception
of symptoms of this syndrome. In the study by Walitt et al. [32], 11 years after receiving
the diagnosis, it was found that these patients showed lower perceptions of fatigue and
other symptoms of FM; in other words, these patients began to report a decrease in the
intensity of these symptoms. These results were also verified in the study by Kennedy
and Felson [31], where after 10 years following diagnosis, these patients also reported
decreased levels of fatigue. The study by White et al. [36] also monitored patients newly
diagnosed with FM, and found that three years after receiving diagnosis, these patients
reported lower values of fatigue and symptoms of FM.
4.4. Limitations
Present research has some limitations that should be acknowledged. First, this study
had a cross-sectional design and longitudinal/experimental studies can be helpful in
measuring temporal/longitudinal variance of fatigue-related symptoms in both countries.
Another limitation of the present study that should be acknowledged is that we did not
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measure pain severity and intensity. As previously mentioned, fatigue does not occur in
isolation; rather, it is concurrently present and varies in severity with other symptoms such
as chronic pain, sleep disorders, and other cognitive difficulties. Since both are important
in the diagnosis of FM, future studies should examine pain and fatigue-related symptoms
of FM and explore possible associations between them. Third, the findings of this study
cannot be used for comparison between other cultures, as more research is needed to
establish this comparative pattern. Therefore, future studies should explore fatigue-related
symptoms across more cultures and compare results with current evidence.
5. Conclusions
The uniqueness of this study is the emphasis on the proper use of a valid and invariant
measure of fatigue-related symptoms in patients with FM. This was the first study that
carried out this type of comparison between these two countries. Overall, there are
significant differences in fatigue symptoms between Portuguese and Brazilian women
with FM, suggesting that cultural and geographical differences should be considered when
describing fatigue-related symptoms in women with FM. Further in-depth studies are
needed to assess these factors specifically. In addition, the present study showed that age
and time of diagnosis are not associated with fatigue in Portuguese and Brazilian women
with FM. The analysis of fatigue components between Portuguese and Brazilians brings
new contributions to the literature in the scope of FM, where it reinforces the importance
of the robust evaluation of difference in perception of fatigue between different cultures.
In general, the findings of this study provide new literature involving the examination of
fatigue and may assist future research involving cross-cultural investigations considering
patients with FM.
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